CARB-X Day Zero Diagnostics Secures Additional $8.2M From CARB-X The funding will support product development for Day Zero's whole-genome sequencing and machine learning-based diagnostic. CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC SpeeDx will develop a rapid, portable test for chlamydia and gonorrhea that can determine the latter's antimicrobial susceptibility, as well. CARB-X Awards GenomeKey Up to $9.5M to Develop Rapid Diagnostic Test for Sepsis GenomeKey's technology combines methods to separate bacterial and human DNA, next-generation sequencing, and machine learning. Baebies Awarded up to $11.6M in CARB-X Funding for Neonatal Sepsis Test The rapid, point-of-care test is being developed to run on the Durham, North Carolina-based company's Finder digital microfluidics instrument. CARB-X Commits up to $13.8M to Novel Microdevices for Point-of-Care STI Test Novel Microdevices is developing a portable, sample-to-answer instrument that is designed to perform molecular testing on untreated patient samples. Breaking News Rare Kidney Cancer Genomic Analysis Reveals Potential Target, Suggests Treatment SEC Concludes CareDx Investigation, Recommends No Enforcement Action Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance Adela Closes $48M Financing to Develop Cancer Monitoring, Early Detection Test 3EO Health At-Home Molecular COVID-19 Test Nabs FDA EUA The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.